Comparison of robotic- and laparoscopic-assisted gastrectomy in advanced gastric cancer: updated short- and long-term results

2018 ◽  
Vol 33 (2) ◽  
pp. 528-534 ◽  
Author(s):  
Yunhe Gao ◽  
Hongqing Xi ◽  
Zhi Qiao ◽  
Jiyang Li ◽  
Kecheng Zhang ◽  
...  
2021 ◽  
Vol 13 (2) ◽  
pp. 116-122
Author(s):  
Serdar Çulcu ◽  
Cemil Yüksel ◽  
Salim Demirci ◽  
Ali Ekrem Ünal ◽  
Sancar Bayar ◽  
...  

2018 ◽  
Vol 36 (4) ◽  
pp. 331-339
Author(s):  
Alberto Biondi ◽  
Domenico D’Ugo ◽  
Ferdinando Cananzi ◽  
Stefano Rausei ◽  
Federico Sicoli ◽  
...  

Introduction: The role of gastric resection in treating metastatic gastric adenocarcinoma is controversial. In the present study, we reviewed the short- and long-term outcomes of stage IV patients undergoing surgery. Methods: A retrospective review was conducted that assessed patients undergoing elective surgery for incurable gastric carcinoma. Short- and long-term results were evaluated. Results: A total of 122 stage IV gastric cancer patients were assessed. Postoperative mortality was 5.7%, and the overall rate of complications was 35.2%. The overall survival rate at 1 and 3 years was 58 and 19% respectively; the median survival was 14 months. Improved survival was observed for the factors age less than 60 years (p = 0.015), site of metastases (p = 0.022), extended lymph node dissection (p = 0.044), absence of residual disease after surgery (p = 0.001), and administration of adjuvant chemotherapy (p = 0.016). Multivariate analysis showed that residual disease and adjuvant chemotherapy were independent prognostic factors. Conclusions: The results of this study suggest that surgery combined with systemic chemotherapy in selected patients with stage IV gastric cancer can improve survival.


2018 ◽  
Vol 27 (2) ◽  
pp. 146-153 ◽  
Author(s):  
Jinning Ye ◽  
Yufeng Ren ◽  
Zhewei Wei ◽  
Xun Hou ◽  
Weigang Dai ◽  
...  

Author(s):  
Armands Sīviņš ◽  
Jānis Misiņš ◽  
Corrado Pedrazzani ◽  
Guntis Ancāns ◽  
Aivars Stengrēvics ◽  
...  

Epidemiology and Surgical Treatment of Gastric Cancer in Latvia The aim of the study was to evaluate short- and long-term results of surgical treatment of gastric cancer performed in Latvia Oncology Centre. Retrospectively data was collected from 461 patients who underwent gastrectomy with curative intent in the Latvia Oncology Centre from January 2001 to December 2005. The data was subjected to statistical analysis. On average, 92.2 (range 81-102) R0-R1 gastrectomies were performed each year. Post-operative complications occurred in 75 patients (16.3%); in-hospital mortality was 3.3%. The overall 5-year survival was 50.8%. In 444 cases (96.3%) there was histopathologic confirmation of R0-resection with a 5-year survival of 52.5% (P < 0.001). Considering pT category, 5-year survival (median) was 88.6% (not reached) for pT1 patients, 65% (not reached) for pT2, 42.3% (35.7 months) for pT3 and 27% (14.2 months) for pT4 (P < 0.001). Considering the pN category, 5-year survival (median) was 67% (not reached) for pN0 patients, 30% (22.1 months) for pN1 and 29% (14.2 months) for pN2-3 (P < 0.001). Short- as well as long-term results are comparable with Western experiences, but not for pN+ patients where no difference between pN1 and pN2 cases was observed.


Sign in / Sign up

Export Citation Format

Share Document